
Visiopharmrevenue & funding
Other Analytics SoftwareHoersholm, DenmarkFounded 2001CEO Michael Grunkin
Visiopharm is an Other Analytics Software company based in Hoersholm, founded in 2001.
Visiopharm revenue
Visiopharm has not published its revenue. GetLatka estimates it at about $9M a year (October 2024).
All 3 revenue readings, with sources
| As of | Revenue | Source |
|---|---|---|
| Apr 2021 | $6.5M | – |
| Dec 2023 | $7.1MEST. | GetLatka estimate |
| Oct 2024 | $9MEST. | GetLatka estimate |
– source not recorded
Visiopharm funding rounds & investors
Visiopharm has raised $15.5M in one round, in August 2018.
| Date | Round | Raised |
|---|---|---|
| Aug 2018 | Funding round | $15.5M |
| Total raised | $15.5M |
Visiopharm CEO, founders & employees
Michael Grunkin founded Visiopharm in 2001 and runs it as CEO. Visiopharm had 96 employees (December 2024, LinkedIn), down from 105 a year earlier.
- Michael GrunkinFounder & CEO
All 6 headcount readings, with sources
| As of | Employees | Source |
|---|---|---|
| Dec 2024 | 96 | |
| Oct 2024 | 99 | |
| Dec 2023 | 105 | |
| Dec 2022 | 108 | |
| Dec 2021 | 115 | |
| Apr 2021 | 102 | – |
Visiopharm FAQ
What is Visiopharm's revenue?
GetLatka estimates Visiopharm's revenue at about $9M a year (October 2024). The company hasn't published its own figure.
How much funding has Visiopharm raised?
Visiopharm has raised $15.5M in one funding round, in August 2018.
How many employees does Visiopharm have?
Visiopharm had 96 employees in December 2024, according to LinkedIn.
Who is the CEO of Visiopharm?
Michael Grunkin is the CEO of Visiopharm and founded the company in 2001.
Who founded Visiopharm?
Michael Grunkin founded Visiopharm in 2001.
Browse Other Analytics Software
How this page is sourced
5 from public sources · 2 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST. and say whose they are. Not financial advice.
Updated Dec 23, 2024Data disclaimerReport a correctionClaim this profileRun Visiopharm? Join the podcast